Characterization of Susceptibility Variants of Influenza Virus Grown in the Presence of T-705
Author:
Publisher
Japanese Pharmacological Society
Subject
Pharmacology,Molecular Medicine
Link
https://www.jstage.jst.go.jp/article/jphs/126/3/126_14156SC/_pdf
Reference15 articles.
1. 1 Furuta Y, Takahashi K, Shiraki K, Sakamoto K, Smee DF, Barnard DL, et al. T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res. 2009;82:95–102.
2. 2 Sangawa H, Komeno T, Nishikawa H, Yoshida A, Takahashi K, Nomura N, et al. Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase. Antimicrob Agents Chemother. 2013;57:5202–5208.
3. 3 Jin Z, Smith LK, Rajwanshi VK, Kim B, Deval J. The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5’-triphosphate towards influenza A virus polymerase. PLoS One. 2013;8:e68347.
4. 4 Drake JW. Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci U S A. 1993;90:4171–4175.
5. 5 Ida M, Kageyama S, Sato H, Kamiyama T, Yamamura J, Kurokawa M, et al. Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants. Antiviral Res. 1999;40:155–166.
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Assessment of the frequency of SARS-CoV-2 Omicron variant escape from RNA-dependent RNA polymerase inhibitors and 3C-like protease inhibitors;Antiviral Research;2023-08
2. Favipiravir in the Battle with Respiratory Viruses;Mini-Reviews in Medicinal Chemistry;2022-09
3. Antiviral therapy for COVID-19: Derivation of optimal strategy based on past antiviral and favipiravir experiences;Pharmacology & Therapeutics;2022-07
4. Favipiravir Inhibits Hepatitis A Virus Infection in Human Hepatocytes;International Journal of Molecular Sciences;2022-02-27
5. Interface‐based design of the favipiravir‐binding site in SARS‐CoV‐2 RNA‐dependent RNA polymerase reveals mutations conferring resistance to chain termination;FEBS Letters;2021-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3